These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 15464063

  • 21. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ, Giełdoń A, Slusarz R, Ciarkowski J.
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [Abstract] [Full Text] [Related]

  • 22. Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.
    Tahara A, Tsukada J, Tomura Y, Momose K, Suzuki T, Yatsu T, Shibasaki M.
    Eur J Pharmacol; 2006 May 24; 538(1-3):32-8. PubMed ID: 16678155
    [Abstract] [Full Text] [Related]

  • 23. The pituitary mediates the anxiolytic-like effects of the vasopressin V1B receptor antagonist, SSR149415, in a social interaction test in rats.
    Shimazaki T, Iijima M, Chaki S.
    Eur J Pharmacol; 2006 Aug 14; 543(1-3):63-7. PubMed ID: 16843459
    [Abstract] [Full Text] [Related]

  • 24. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF, Koolhaas JM.
    Eur J Pharmacol; 2005 Dec 05; 526(1-3):125-39. PubMed ID: 16310183
    [Abstract] [Full Text] [Related]

  • 25. Characterization of RWJ-351647, a novel nonpeptide vasopressin V2 receptor antagonist.
    Gunnet JW, Matthews JM, Maryanoff BE, de Garavilla L, Andrade-Gordon P, Damiano B, Hageman W, Look R, Stahle P, Streeter AJ, Wines PG, Demarest KT.
    Clin Exp Pharmacol Physiol; 2006 Apr 05; 33(4):320-6. PubMed ID: 16620295
    [Abstract] [Full Text] [Related]

  • 26. Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.
    Tsukamoto I, Koshio H, Akamatsu S, Kuramochi T, Saitoh C, Yatsu T, Yanai-Inamura H, Kitada C, Yamamoto E, Sakamoto S, Tsukamoto S.
    Bioorg Med Chem; 2008 Nov 01; 16(21):9524-35. PubMed ID: 18835174
    [Abstract] [Full Text] [Related]

  • 27. The vasopressin-induced excitation of hypoglossal and facial motoneurons in young rats is mediated by V1a but not V1b receptors, and is independent of intracellular calcium signalling.
    Reymond-Marron I, Tribollet E, Raggenbass M.
    Eur J Neurosci; 2006 Sep 01; 24(6):1565-74. PubMed ID: 17004920
    [Abstract] [Full Text] [Related]

  • 28. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
    Tsukamoto I, Koshio H, Kuramochi T, Saitoh C, Yanai-Inamura H, Kitada-Nozawa C, Yamamoto E, Yatsu T, Shimada Y, Sakamoto S, Tsukamoto S.
    Bioorg Med Chem; 2009 Apr 15; 17(8):3130-41. PubMed ID: 19321349
    [Abstract] [Full Text] [Related]

  • 29. Enhanced reactivity to vasopressin in rat basilar arteries during vasospasm after subarachnoid hemorrhage.
    Nishihashi T, Trandafir CC, Wang A, Ji X, Kurahashi K.
    Eur J Pharmacol; 2005 Apr 18; 513(1-2):93-100. PubMed ID: 15878713
    [Abstract] [Full Text] [Related]

  • 30. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R, Callahan N, Xu Z, Wu N, Thibonnier M, Shoham M.
    J Pharmacol Exp Ther; 2006 Feb 18; 316(2):564-71. PubMed ID: 16234409
    [Abstract] [Full Text] [Related]

  • 31. Blockade of central vasopressin receptors reduces the cardiovascular response to acute stress in freely moving rats.
    Stojicić S, Milutinović-Smiljanić S, Sarenac O, Milosavljević S, Paton JF, Murphy D, Japundzić-Zigon N.
    Neuropharmacology; 2008 Apr 18; 54(5):824-36. PubMed ID: 18339407
    [Abstract] [Full Text] [Related]

  • 32. Vasopressin receptors in voiding dysfunction.
    Pisipati S, Hashim H.
    Handb Exp Pharmacol; 2011 Apr 18; (202):453-83. PubMed ID: 21290239
    [Abstract] [Full Text] [Related]

  • 33. Relaxin-3, INSL5, and their receptors.
    Liu C, Lovenberg TW.
    Results Probl Cell Differ; 2008 Apr 18; 46():213-37. PubMed ID: 18236022
    [Abstract] [Full Text] [Related]

  • 34. Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.
    Chini B, Manning M.
    Biochem Soc Trans; 2007 Aug 18; 35(Pt 4):737-41. PubMed ID: 17635137
    [Abstract] [Full Text] [Related]

  • 35. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles.
    Smeltzer MD, Curtis JT, Aragona BJ, Wang Z.
    Neurosci Lett; 2006 Feb 13; 394(2):146-51. PubMed ID: 16289323
    [Abstract] [Full Text] [Related]

  • 36. Vasopressin facilitates glycinergic and GABAergic synaptic transmission in developing hypoglossal motoneurons.
    Reymond-Marron I, Raggenbass M, Zaninetti M.
    Eur J Neurosci; 2005 Mar 13; 21(6):1601-9. PubMed ID: 15845087
    [Abstract] [Full Text] [Related]

  • 37. Design of benzophenone-containing photoactivatable linear vasopressin antagonists: pharmacological and photoreactive properties.
    Ponthieux S, Cabot J, Mouillac B, Seyer R, Barberis C, Carnazzi E.
    J Med Chem; 2005 May 05; 48(9):3379-88. PubMed ID: 15857144
    [Abstract] [Full Text] [Related]

  • 38. Vaptans and the treatment of water-retaining disorders.
    Quittnat F, Gross P.
    Semin Nephrol; 2006 May 05; 26(3):234-43. PubMed ID: 16713496
    [Abstract] [Full Text] [Related]

  • 39. Periaqueductal gray knockdown of V2, not V1a and V1b receptor influences nociception in the rat. yj6676@yahoo.com.
    Yang J, Yang Y, Chen JM, Wang G, Xu HT, Liu WY, Lin BC.
    Neurosci Res; 2007 Jan 05; 57(1):104-11. PubMed ID: 17056144
    [Abstract] [Full Text] [Related]

  • 40. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
    Tahara A, Tsukada J, Tomura Y, Suzuki T, Yatsu T, Shibasaki M.
    Vascul Pharmacol; 2007 Jun 05; 46(6):463-9. PubMed ID: 17395547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.